Opinion

» policy and clinical trials

Most Recent

image: Opinion: Biobanking Has a Consent Dilemma

Opinion: Biobanking Has a Consent Dilemma

By | July 25, 2017

Is the deep uncertainty surrounding fundamental legal and ethical norms putting biobanks in a precarious position? 

0 Comments

image: Opinion: Token Pharmacovigilance

Opinion: Token Pharmacovigilance

By | May 23, 2017

A US government website for collecting reports of side effects associated with vaccines is broken. Why has no one noticed?

4 Comments

image: Opinion: When Science Meets Activism

Opinion: When Science Meets Activism

By | May 3, 2017

Scientists new to advocacy must find balance between embracing diverse perspectives and guarding against anti-scientific beliefs.

3 Comments

image: Opinion: After We March

Opinion: After We March

By | March 16, 2017

How to become—and stay—involved in science policy 

4 Comments

image: Opinion: Sometimes, Scientists Must March

Opinion: Sometimes, Scientists Must March

By , , and | February 13, 2017

Lessons learned from the “Death of Evidence” demonstration in Canada

9 Comments

image: Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

Opinion: Improving FDA Evaluations Without Jeopardizing Safety and Efficacy

By | February 1, 2017

What can be done to lower development costs and drug prices?

4 Comments

New approaches to treating cancer have shown great promise, but they also come with serious risks that give us cause for concern.

1 Comment

image: Book Review: <em>Personal Trials</em>

Book Review: Personal Trials

By | March 22, 2016

At first blush, do-it-yourself clinical trials seem pointless and reckless. But a deeper truth pervades the research and the patients who drive it forward.

0 Comments

image: Opinion: Why Most TBI Studies Fail

Opinion: Why Most TBI Studies Fail

By | February 24, 2016

Thoughts on how to redesign clinical trials for traumatic brain injury

1 Comment

image: Opinion: Public Data, Private Concerns

Opinion: Public Data, Private Concerns

By | May 20, 2015

Research participants aren’t always clear on open data policies when consenting to studies.

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Grass Routes
    Features Grass Routes

    Researchers are discovering a suite of new locations and functions of endocannabinoid receptors that play roles in sickness and in health.

  3. Studies Retracted After UCLA Investigation
  4. Trump Nominates Sam Clovis to Lead USDA Research
AAAS